Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial

IMPORTANCE: Clinicians recommend enteric-coated aspirin to decrease gastrointestinal bleeding in secondary prevention of coronary artery disease even though studies suggest platelet inhibition is decreased with enteric-coated vs uncoated aspirin formulations. OBJECTIVE: To assess whether receipt of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sleem, Amber, Effron, Mark B., Stebbins, Amanda, Wruck, Lisa M., Marquis-Gravel, Guillaume, Muñoz, Daniel, Re, Richard N., Gupta, Kamal, Pepine, Carl J., Jain, Sandeep K., Girotra, Saket, Whittle, Jeffrey, Benziger, Catherine P., Farrehi, Peter M., Knowlton, Kirk U., Polonsky, Tamar S., Roe, Matthew T., Rothman, Russell L., Harrington, Robert A., Jones, W. Schuyler, Hernandez, Adrian F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551818/
https://www.ncbi.nlm.nih.gov/pubmed/37792369
http://dx.doi.org/10.1001/jamacardio.2023.3364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551818/
https://www.ncbi.nlm.nih.gov/pubmed/37792369
http://dx.doi.org/10.1001/jamacardio.2023.3364

Ejemplares similares